Last 12 months
Inside the activity.
2 purchase rows · 112 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 26 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 56 |
| Sep 2026 | 0 | 12 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 30, 2017 Filed Feb 1, 2017 00:31 UTC |
OSTADAN OMEADEVP Ops, Products, Strategy
|
SaleCommon Stock | 259 | $160.90 | $41,673.10 |
DisclosureSEC source: 0001127602-17-003222 · form4.xml · nonDerivative · entry 2 OSTADAN OMEAD · CIK 0001642678 · EVP Ops, Products, Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,690 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 00:31 UTC |
OSTADAN OMEADEVP Ops, Products, Strategy
|
Tax withholdingCommon Stock | 713 | $159.28 | $113,566.64 |
DisclosureSEC source: 0001127602-17-003222 · form4.xml · nonDerivative · entry 1 OSTADAN OMEAD · CIK 0001642678 · EVP Ops, Products, Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,949 Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 00:29 UTC |
HENRY CHRISTIAN OEVP & Chief Commercial Officer
|
Tax withholdingCommon Stock | 795 | $159.28 | $126,627.60 |
DisclosureSEC source: 0001127602-17-003220 · form4.xml · nonDerivative · entry 1 HENRY CHRISTIAN O · CIK 0001263805 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,531 Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 00:26 UTC |
FLATLEY JAY TDirector
|
Tax withholdingCommon Stock | 2,784 | $159.28 | $443,435.52 |
DisclosureSEC source: 0001127602-17-003214 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498,453 Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 00:24 UTC |
Dadswell CharlesSr VP & General Counsel
|
Tax withholdingCommon Stock | 256 | $159.28 | $40,775.68 |
DisclosureSEC source: 0001127602-17-003212 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · Sr VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,164 Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 00:22 UTC |
Bouchard MichelChief Accounting Officer
|
Tax withholdingCommon Stock | 798 | $159.28 | $127,105.44 |
DisclosureSEC source: 0001127602-17-003210 · form4.xml · nonDerivative · entry 1 Bouchard Michel · CIK 0001566173 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,410 Read SEC document |
| January 26, 2017 Filed Jan 31, 2017 02:18 UTC |
DORSA CAROLINEDirector
|
GrantCommon Stock | 4,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-003005 · form4.xml · nonDerivative · entry 1 DORSA CAROLINE · CIK 0001181174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,996 F1 · shares: Grant of restricted stock units with 25% of the shares subject to the award vesting on each of the first, second, third and fourth anniversaries of the date of grant, subject to the awardee's continuing to be a service provider on such dates. Read SEC document |
| January 19, 2017 Filed Jan 19, 2017 22:56 UTC |
OSTADAN OMEADEVP Ops, Products, Strategy
|
SaleCommon Stock | 378 | $160.35 | $60,612.30 |
DisclosureSEC source: 0001127602-17-002107 · form4.xml · nonDerivative · entry 2 OSTADAN OMEAD · CIK 0001642678 · EVP Ops, Products, Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,662 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 22:56 UTC |
OSTADAN OMEADEVP Ops, Products, Strategy
|
SaleCommon Stock | 2,000 | $160.00 | $320,000.00 |
DisclosureSEC source: 0001127602-17-002107 · form4.xml · nonDerivative · entry 1 OSTADAN OMEAD · CIK 0001642678 · EVP Ops, Products, Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,040 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 11, 2017 Filed Jan 14, 2017 00:05 UTC |
BOWMAN A BLAINEDirector
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $42.82 | $0.00 |
DisclosureSEC source: 0001127602-17-001702 · form4.xml · derivative · entry 9 BOWMAN A BLAINE · CIK 0001008891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 3,000 shares Expires 2020-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 11, 2017 Filed Jan 14, 2017 00:05 UTC |
BOWMAN A BLAINEDirector
|
SaleCommon Stock | 200 | $164.93 | $32,986.00 |
DisclosureSEC source: 0001127602-17-001702 · form4.xml · nonDerivative · entry 6 BOWMAN A BLAINE · CIK 0001008891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,704 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 200 shares sold ranging from $164.91 to $164.95 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 11, 2017 Filed Jan 14, 2017 00:05 UTC |
BOWMAN A BLAINEDirector
|
SaleCommon Stock | 705 | $164.03 | $115,639.04 |
DisclosureSEC source: 0001127602-17-001702 · form4.xml · nonDerivative · entry 5 BOWMAN A BLAINE · CIK 0001008891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,904 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 705 shares sold ranging from $163.80 to $164.44 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 11, 2017 Filed Jan 14, 2017 00:05 UTC |
BOWMAN A BLAINEDirector
|
SaleCommon Stock | 695 | $163.06 | $113,323.92 |
DisclosureSEC source: 0001127602-17-001702 · form4.xml · nonDerivative · entry 4 BOWMAN A BLAINE · CIK 0001008891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,609 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 695 shares sold ranging from $162.79 to $163.48 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 11, 2017 Filed Jan 14, 2017 00:05 UTC |
BOWMAN A BLAINEDirector
|
SaleCommon Stock | 1,200 | $162.15 | $194,575.20 |
DisclosureSEC source: 0001127602-17-001702 · form4.xml · nonDerivative · entry 3 BOWMAN A BLAINE · CIK 0001008891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,304 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 1,200 shares sold ranging from $161.77 to $162.53 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 11, 2017 Filed Jan 14, 2017 00:05 UTC |
BOWMAN A BLAINEDirector
|
SaleCommon Stock | 200 | $160.67 | $32,134.00 |
DisclosureSEC source: 0001127602-17-001702 · form4.xml · nonDerivative · entry 2 BOWMAN A BLAINE · CIK 0001008891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,504 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 200 shares sold ranging from $160.47 to $160.87 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 11, 2017 Filed Jan 14, 2017 00:05 UTC |
BOWMAN A BLAINEDirector
|
Exercise / conversionCommon Stock | 3,000 | $42.82 | $128,460.00 |
DisclosureSEC source: 0001127602-17-001702 · form4.xml · nonDerivative · entry 1 BOWMAN A BLAINE · CIK 0001008891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 10, 2017 Filed Jan 13, 2017 02:36 UTC |
Dadswell CharlesSr VP & General Counsel
|
SaleCommon Stock | 116 | $161.60 | $18,745.60 |
DisclosureSEC source: 0001127602-17-001637 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · Sr VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,420 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · balance_after: Balance reflects reduction of 33,750 shares which were previously inadvertently included in total, and addition of 196 shares purchased through Employee Stock Purchase Plan. Read SEC document |
| January 06, 2017 Filed Jan 13, 2017 01:36 UTC |
SAMAD SAMSr. VP and CFO
|
GrantPerformance Shares · Derivative | 6,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001632 · form4.xml · derivative · entry 2 SAMAD SAMER ABDUL · CIK 0001694295 · Sr. VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,626 Underlying: Common Stock · 6,626 shares Expires 2019-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · shares: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| January 06, 2017 Filed Jan 13, 2017 01:36 UTC |
SAMAD SAMSr. VP and CFO
|
GrantCommon Stock | 2,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001632 · form4.xml · nonDerivative · entry 1 SAMAD SAMER ABDUL · CIK 0001694295 · Sr. VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,209 F1 · shares: Grant of restricted stock units with 25% of the shares subject to the award vesting on each of the first, second, third and fourth anniversaries of the date of grant, subject to the awardee's continuing to be a service provider on such dates. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:59 UTC |
BRADBURY DANIELDirector
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 600 | $0.00 Strike: $71.09 | $0.00 |
DisclosureSEC source: 0001127602-17-001310 · form4.xml · derivative · entry 4 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 600 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:59 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 400 | $135.56 | $54,223.20 |
DisclosureSEC source: 0001127602-17-001310 · form4.xml · nonDerivative · entry 3 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,465 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 400 shares sold ranging from $135.31 to $135.98 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:59 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 200 | $133.93 | $26,785.00 |
DisclosureSEC source: 0001127602-17-001310 · form4.xml · nonDerivative · entry 2 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,865 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 200 shares sold ranging from $133.47 to $134.38 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:59 UTC |
BRADBURY DANIELDirector
|
Exercise / conversionCommon Stock | 600 | $71.09 | $42,654.00 |
DisclosureSEC source: 0001127602-17-001310 · form4.xml · nonDerivative · entry 1 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 16, 2016 Filed Dec 21, 2016 00:59 UTC |
deSouza Francis ADirector · President and CEO
|
Tax withholdingCommon Stock | 1,938 | $131.01 | $253,897.38 |
DisclosureSEC source: 0001127602-16-070615 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,205 Read SEC document |
| December 15, 2016 Filed Dec 20, 2016 01:08 UTC |
OSTADAN OMEADEVP Ops, Products, Strategy
|
SaleCommon Stock | 2,000 | $126.16 | $252,320.00 |
DisclosureSEC source: 0001127602-16-070499 · form4.xml · nonDerivative · entry 1 OSTADAN OMEAD · CIK 0001642678 · EVP Ops, Products, Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,040 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · balance_after: Balance reflects reduction of 20,063 shares which were previously inadvertently included in total, and addition of 115 shares purchased through the Company's Employee Stock Purchase Plan. Read SEC document |
| December 12, 2016 Filed Dec 15, 2016 01:09 UTC |
BRADBURY DANIELDirector
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 600 | $0.00 Strike: $71.09 | $0.00 |
DisclosureSEC source: 0001127602-16-070056 · form4.xml · derivative · entry 4 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,600 Underlying: Common Stock · 600 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 12, 2016 Filed Dec 15, 2016 01:09 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 400 | $123.98 | $49,593.20 |
DisclosureSEC source: 0001127602-16-070056 · form4.xml · nonDerivative · entry 3 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,465 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 400 shares sold ranging from $123.80 to $124.28 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| December 12, 2016 Filed Dec 15, 2016 01:09 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 200 | $122.31 | $24,461.00 |
DisclosureSEC source: 0001127602-16-070056 · form4.xml · nonDerivative · entry 2 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,865 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 200 shares sold ranging from $122.20 to $122.41 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| December 12, 2016 Filed Dec 15, 2016 01:09 UTC |
BRADBURY DANIELDirector
|
Exercise / conversionCommon Stock | 600 | $71.09 | $42,654.00 |
DisclosureSEC source: 0001127602-16-070056 · form4.xml · nonDerivative · entry 1 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 08, 2016 Filed Dec 9, 2016 21:18 UTC |
OSTADAN OMEADEVP Ops, Products, Strategy
|
SaleCommon Stock | 3,000 | $121.63 | $364,890.00 |
DisclosureSEC source: 0001127602-16-069584 · form4.xml · nonDerivative · entry 1 OSTADAN OMEAD · CIK 0001642678 · EVP Ops, Products, Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,988 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 01:25 UTC |
FLATLEY JAY TDirector
|
GrantCommon Stock | 15,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-069359 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 501,237 F1 · shares: Grant of restricted stock units that vest as follows: 100% of the Shares subject to the Award become vested on December 5, 2017, subject to Awardee's continuing to be a Service Provider on such date. Read SEC document |
| December 02, 2016 Filed Dec 7, 2016 01:23 UTC |
deSouza Francis ADirector · President and CEO
|
GrantPerformance Shares · Derivative | 35,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-069357 · form4.xml · derivative · entry 2 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,184 Underlying: Common Stock · 35,184 shares Expires 2019-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · shares: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| December 02, 2016 Filed Dec 7, 2016 01:23 UTC |
deSouza Francis ADirector · President and CEO
|
GrantCommon Stock | 11,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-069357 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,143 F1 · shares: Grant of restricted stock units that vest as follows: 25% of the shares subject to the award become vested on November 5, 2017, November 5, 2018, November 5, 2019, and November 5, 2020, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| December 02, 2016 Filed Dec 7, 2016 01:21 UTC |
Stapley MarcEVP & Chief Administrative Ofc
|
GrantPerformance Shares · Derivative | 13,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-069355 · form4.xml · derivative · entry 2 Stapley Marc · CIK 0001539796 · EVP & Chief Administrative Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,488 Underlying: Common Stock · 13,488 shares Expires 2019-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · shares: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| December 02, 2016 Filed Dec 7, 2016 01:21 UTC |
Stapley MarcEVP & Chief Administrative Ofc
|
GrantCommon Stock | 4,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-069355 · form4.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · EVP & Chief Administrative Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,545 F1 · shares: Grant of restricted stock units that vest as follows: 25% of the shares subject to the award become vested on November 5, 2017, November 5, 2018, November 5, 2019, and November 5, 2020, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| December 02, 2016 Filed Dec 7, 2016 01:17 UTC |
OSTADAN OMEADEVP Ops, Products, Strategy
|
GrantPerformance Shares · Derivative | 13,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-069351 · form4.xml · derivative · entry 2 OSTADAN OMEAD · CIK 0001642678 · EVP Ops, Products, Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,488 Underlying: Common Stock · 13,488 shares Expires 2019-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · shares: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| December 02, 2016 Filed Dec 7, 2016 01:17 UTC |
OSTADAN OMEADEVP Ops, Products, Strategy
|
GrantCommon Stock | 4,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-069351 · form4.xml · nonDerivative · entry 1 OSTADAN OMEAD · CIK 0001642678 · EVP Ops, Products, Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,988 F1 · shares: Grant of restricted stock units that vest as follows: 25% of the shares subject to the award become vested on November 5, 2017, November 5, 2018, November 5, 2019, and November 5, 2020, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| December 02, 2016 Filed Dec 7, 2016 01:19 UTC |
Ronaghi MostafaSr VP & CTO
|
GrantPerformance Shares · Derivative | 11,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-069353 · form4.xml · derivative · entry 2 Ronaghi Mostafa · CIK 0001441876 · Sr VP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,728 Underlying: Common Stock · 11,728 shares Expires 2019-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · shares: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| December 02, 2016 Filed Dec 7, 2016 01:19 UTC |
Ronaghi MostafaSr VP & CTO
|
GrantCommon Stock | 3,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-069353 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · Sr VP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,417 F1 · shares: Grant of restricted stock units that vest as follows: 25% of the shares subject to the award become vested on November 5, 2017, November 5, 2018, November 5, 2019, and November 5, 2020, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| December 02, 2016 Filed Dec 7, 2016 01:14 UTC |
Dadswell CharlesSr VP & General Counsel
|
GrantPerformance Shares · Derivative | 7,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-069349 · form4.xml · derivative · entry 2 Dadswell Charles · CIK 0001575229 · Sr VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,624 Underlying: Common Stock · 7,624 shares Expires 2019-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · shares: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| December 02, 2016 Filed Dec 7, 2016 01:14 UTC |
Dadswell CharlesSr VP & General Counsel
|
GrantCommon Stock | 2,542 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-069349 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · Sr VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,090 F1 · shares: Grant of restricted stock units that vest as follows: 25% of the shares subject to the award become vested on November 5, 2017, November 5, 2018, November 5, 2019, and November 5, 2020, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| December 02, 2016 Filed Dec 7, 2016 01:11 UTC |
Bouchard MichelChief Accounting Officer
|
GrantPerformance Shares · Derivative | 2,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-069347 · form4.xml · derivative · entry 2 Bouchard Michel · CIK 0001566173 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,737 Underlying: Common Stock · 2,737 shares Expires 2019-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · shares: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| December 02, 2016 Filed Dec 7, 2016 01:11 UTC |
Bouchard MichelChief Accounting Officer
|
GrantCommon Stock | 2,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-069347 · form4.xml · nonDerivative · entry 1 Bouchard Michel · CIK 0001566173 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,208 F1 · shares: Grant of restricted stock units that vest as follows: 25% of the shares subject to the award become vested on November 5, 2017, November 5, 2018, November 5, 2019, and November 5, 2020, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 23:41 UTC |
OSTADAN OMEADEVP Ops, Products, Strategy
|
SaleCommon Stock | 3,000 | $133.30 | $399,900.00 |
DisclosureSEC source: 0001127602-16-069185 · form4.xml · nonDerivative · entry 1 OSTADAN OMEAD · CIK 0001642678 · EVP Ops, Products, Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,492 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 23:14 UTC |
BRADBURY DANIELDirector
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 600 | $0.00 Strike: $71.09 | $0.00 |
DisclosureSEC source: 0001127602-16-067262 · form4.xml · derivative · entry 3 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Underlying: Common Stock · 600 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 23:14 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 600 | $136.34 | $81,802.98 |
DisclosureSEC source: 0001127602-16-067262 · form4.xml · nonDerivative · entry 2 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,465 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 600 shares sold ranging from $136.05 to $136.94 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 23:14 UTC |
BRADBURY DANIELDirector
|
Exercise / conversionCommon Stock | 600 | $71.09 | $42,654.00 |
DisclosureSEC source: 0001127602-16-067262 · form4.xml · nonDerivative · entry 1 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 01:25 UTC |
Dadswell CharlesSr VP & General Counsel
|
Tax withholdingCommon Stock | 352 | $137.08 | $48,252.16 |
DisclosureSEC source: 0001127602-16-066461 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · Sr VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,548 Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 01:37 UTC |
Ronaghi MostafaSr VP & CTO
|
Tax withholdingCommon Stock | 440 | $137.08 | $60,315.20 |
DisclosureSEC source: 0001127602-16-066470 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · Sr VP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,507 Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 01:46 UTC |
deSouza Francis ADirector · President and CEO
|
Tax withholdingCommon Stock | 1,182 | $137.08 | $162,028.56 |
DisclosureSEC source: 0001127602-16-066477 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,415 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.